NARODOWY FUNDUSZ ZDROWIA
Active in Poland as both buyer and supplier — issued 11 contracts, and won 8 contracts, most recently 12 months ago.
Top 5 suppliers won 98% of awarded value — £60.6m of £61.7m across 14 awards.
This contract opportunity involves a medication program aimed at preventing bone complications in adult patients with advanced cancer affecting the bones. The treatment will utilize Denosumab, a medication designed to help manage these complications. Suppliers are invited to provide the necessary se
